Corcept Therapeutics Incorporated logo
Corcept Therapeutics Incorporated CORT
$ 57.52 2.86%

Quarterly report 2024-Q3
added 10-30-2024

report update icon

Corcept Therapeutics Incorporated Cash Conversion Cycle 2011-2024 | CORT

Annual Cash Conversion Cycle Corcept Therapeutics Incorporated

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-410 -238 -235 -230 -116 -222 -346 51.2 141 -235 -3.23 K -11.8 K -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
141 -11.8 K -1.4 K

Quarterly Cash Conversion Cycle Corcept Therapeutics Incorporated

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-316 -266 -232 -260 -145 -144 - -59.5 -133 -196 - -193 -192 -248 27.9 -396 -390 -166 20.7 -111 -115 -181 24 -222 -254 -267 26.2 -342 -432 41.6 - - - - - 127 74.2 -48.6 - -264 -288 -515 - -2.93 K -5.1 K -9.66 K - -11.2 K -5.61 K - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
127 -11.2 K -1.04 K